Demant
Health Care Equipment
Denmark
ESRS disclosure: ESRS E1 \ DR E1-1 \ Paragraph 16 c
Tags Tree
Selected: 0
No matching results found.
- Provide a detailed account of your organization's significant operational and capital expenditures necessary for the execution of your climate change mitigation transition plan, as outlined in Disclosure Requirement E1-1. This should include an explanation and quantification of investments and funding, referencing the key performance indicators of taxonomy-aligned capital expenditures, and, where applicable, the capital expenditure plans disclosed in accordance with Commission Delegated Regulation (EU) 2021/2178.
-
Question Id: E1-1_04
The financial resources required for the implementation of the decarbonisation levers and their relation to the financial statements are yet to be determined, as this depends on further defining the decarbonisation levers and their mitigation actions.
Report Date: 4Q2024Relevance: 30%
- Provide a detailed account of the effects of significant events and changes in circumstances, specifically related to your greenhouse gas emissions, that have transpired between the reporting dates of entities within your value chain and the date of your general purpose financial statements. Ensure this disclosure aligns with the requirements outlined in Disclosure Requirement E1-9, considering any material physical and transition risks, as well as potential climate-related opportunities. Note that quantification of financial effects from opportunities is not mandatory if it does not adhere to the qualitative characteristics of useful information as specified in ESRS 1 Appendix B.
-
Question Id: E1-6_16
In 2024, Demant changed its Scope 3 accounting policy by applying a new, more accurate method. The comparative and baseline figures have been adjusted accordingly. For 2024, the total effect of the change in accounting policy is estimated to be approximately 250,000 tonnes lower CO2e compared to the previous method.
Report Date: 4Q2024Relevance: 65%